Fujisawa Pharmaceutical Articles
TOKYO STOCK COMMENT
14 December 1992
FUJISAWA LAUNCHES HEART DRUG ANTUP
12 October 1992
FUJISAWA DEAL
7 September 1992
Tokyo Stock Comment
29 June 1992
CONSOLIDATED RESULTS FROM JAPAN
29 June 1992
New President at Fujisawa
22 June 1992
rIGF-1 AND LARON-TYPE DWARFISM
1 June 1992
FUJISAWA LAUNCHES NOVACT M
25 May 1992
FUJISAWA LAUNCHES SELOKEN L IN JAPAN
18 May 1992
FUJISAWA TAIWAN PLANT PLANNED
13 April 1992
FUJISAWA TAIWAN PLANT PLANNED
13 April 1992
FUJISAWA FILES IND FOR FK-506
27 January 1992
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
